Table of Content


Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of protein-deficient diseases
3.2.1.2 Increase in adoption of protein drugs over non-protein drugs
3.2.1.3 Increasing research & development activities in the biopharmaceutical industry
3.2.1.4 Growing funding opportunities for protein engineering
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs of protein engineering techniques
3.2.2.2 Limited availability of qualified researchers
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutess
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Reagents
5.4 Software & services
Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)
6.1 Key trends
6.2 Irrational protein design
6.3 Rational protein design
Chapter 7 Market Estimates and Forecast, By Protein Type, 2018 - 2032 ($ Mn)
7.1 Key trends
7.2 Insulin
7.3 Monoclonal antibodies
7.4 Vaccines
7.5 Growth factors
7.6 Coagulation factors
7.7 Interferon
7.8 Other protein types
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)
8.1 Key trends
8.2 Academic research institutes
8.3 Contract research organizations (CROs)
8.4 Pharmaceutical & biotechnology companies
Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Agilent Technologies, Inc.
10.2 Amgen Inc.
10.3 Bio-Rad Laboratories, Inc.
10.4 Bristol Myers Squibb Company
10.5 Bruker Corporation
10.6 Danaher Corporation
10.7 Genentech, Inc.
10.8 Integrated DNA Technologies, Inc.
10.9 Lonza Group
10.10 Merck KGaA
10.11 Thermo Fisher Scientific Inc.
10.12 Vertex Pharmaceuticals Incorporated